On Demand Webinars
-
Addressing Industry Challenges In mRNA Product Commercialization
While the speed of production and flexibility of mRNA are appealing, several industry challenges must still be addressed to realize the full potential and further expand its use.
-
New Approaches For Targeted Drug Delivery With Nanomedicines
4/13/2022
Nanomedicine is a branch of medicine that seeks to apply nanotechnology for disease prevention and/or treatment, imaging, diagnosis, monitoring, and the repair and regeneration of biological systems.
-
How To Value Automation With The Return On Invested Capital Model
6/4/2024
Gain insight into the Return on Invested Capital (ROIC) advantages of an automated manufacturing facility and its correlation to the digital maturity of your operation.
-
How To Bring (Any) mRNA To Life: Simplifying Nucleic Acid Encapsulation
5/6/2024
New technologies for the encapsulation of nucleic acids, such as FDmiX, can potentially overcome limitations of currently available standard mixing technologies.
-
Overcome The Hidden Complexities Of mRNA Process Development
3/22/2023
Explore the challenges behind the perceived simplicity of mRNA process development, as well as characterization strategies and models for predicting process outcomes at early stages.
-
Plasmid DNA Downstream Purification Process
4/11/2023
Large scale production of plasmid DNA requires an in-depth understanding and optimization of the entire downstream process. Explore a complete solution, from harvest to bulk filtration.
-
Planning for Success: Supply Resiliency Strategies for Bench to Production
10/18/2023
Build scalable material sourcing strategies for R&D and early phases through to commercialization and learn how to accelerate the development process and ensure the scalability of your biologics.
-
The Synergistic Role Of Drug Safety In Clinical Trial Operations
4/25/2024
Delve into the significance of adept interpersonal leadership within your drug safety program, shedding light on the operational and financial benefits that stem from fostering a collaborative environment.
-
mRNA/saRNA Manufacturing: Accelerate The Path To Clinic
3/22/2021
Discover key upstream and downstream considerations for process development for RNA drug substance manufacturing and the parameters that need construct-specific optimization to increase yield and reduce impurities.
-
Molecular And Colloidal Ionization Properties Of Lipid Nanoparticle mRNA Vaccines
4/13/2022
Dr. Michael Buschmann, George Mason University, presents an overview of molecular and colloidal ionization properties of lipid nanoparticle mRNA vaccines.